After all we don't let the pharmaceutical companies determine if a drug is safe.
The feds may well outsource ratings to private companies but those companies are no longer beholden to the issuer of the debt.
After all we don't let the pharmaceutical companies determine if a drug is safe.
The feds may well outsource ratings to private companies but those companies are no longer beholden to the issuer of the debt.